BioSpace News Archive

Press Releases

CDA Issues Positive Reimbursement Recommendation for SKYCLARYS™ (omaveloxolone), the Only Health Canada-Approved Treatment for Managing Friedreich Ataxia

July 30, 2025
·
4 min read
Press Releases

CytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights

July 30, 2025
·
7 min read
Press Releases

BriaCell’s Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents

July 30, 2025
·
5 min read
Press Releases

Maziar Mike Doustdar appointed as president and chief executive officer of Novo Nordisk

July 30, 2025
·
6 min read
Press Releases

Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update

July 30, 2025
·
6 min read
Press Releases

Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU

July 30, 2025
·
2 min read
Press Releases

Lilly’s Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) BTK inhibitor, met its primary endpoint in a head-to-head Phase 3 trial versus Imbruvica (ibrutinib) in CLL/SLL

July 30, 2025
·
16 min read
Press Releases

Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease

July 30, 2025
·
11 min read
Press Releases

MIRA Pharmaceuticals Announces FDA Clearance of IND for Ketamir-2, Enabling U.S. Clinical Trials in Neuropathic Pain

July 30, 2025
·
8 min read
Press Releases

ARTBIO Announces $132 Million Series B Financing to Advance Pipeline of Alpha Radioligand Therapies and Expand Manufacturing and Supply Chain Infrastructure

July 30, 2025
·
3 min read